Guardant Health, Inc. R&D Expense 2016-2026 | GH
Beta
What is r&d expense?
Research and development expense represents the costs incurred in discovering and developing new products, processes, or technologies.
What is Guardant Health, Inc.'s current r&d expense?
Guardant Health, Inc. (GH) annual r&d expense for 2025 was $364.2M, a 4.73% increase from 2024. Guardant Health, Inc. r&d expense for the quarter ending March 31, 2026 was $91.0M.
What was Guardant Health, Inc.'s r&d expense in 2024?
Guardant Health, Inc. annual r&d expense for 2024 was $347.8M, a 5.29% decline from 2023.
What was Guardant Health, Inc.'s r&d expense in 2023?
Guardant Health, Inc. annual r&d expense for 2023 was $367.2M, a 1.77% decline from 2022.
What is Guardant Health, Inc.'s 5-year r&d expense CAGR?
Guardant Health, Inc. r&d expense grew at a compound annual growth rate (CAGR) of 19.43% from FY2020 to FY2025, going from $149.9M to $364.2M over 5 years.
R&D Expense History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR+19.4%
FY2020
$149.9M
→
FY2025
$364.2M
16171819202122232425
5 years selected
Company: Guardant Health, Inc.Ticker: GHSector: HealthcareIndustry: Services-Medical LaboratoriesView company profile →